BAY11 enhances OCT4 synthetic mRNA expression in adult human skin cells

Stem Cell Research and Therapy

Volumn 4, Issue 1, 2013, Pages

  Awe, Jason P ^a,b   Crespo, Agustin Vega ^a,b   Li, You ^c   Kiledjian, Megerditch ^c   Byrne, James A ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c RUTGERS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 (4 METHYLPHENYLSULFONYL) 2 PROPENENITRILE; B18R; BX795; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; OCTAMER TRANSCRIPTION FACTOR 4; OSTEOPONTIN; SMALL MOLECULE TRANSPORT AGENT; SYNTHETIC MESSENGER RNA; UNCLASSIFIED DRUG; 3-(4-METHYLPHENYLSULFONYL)-2-PROPENENITRILE; MCT9 PROTEIN, HUMAN; MONOCARBOXYLATE TRANSPORTER; NITRILE; POU5F1 PROTEIN, HUMAN; SULFONE;

ADULT; ARTICLE; CELL ASSAY; CELL PROLIFERATION; CONTROLLED STUDY; DUAL SPECIFICITY PROTEIN PHOSPHATASE 4 GENE; EMBRYO; EMBRYONIC STEM CELL; GENE; GENE EXPRESSION; GENE TARGETING; GENETIC ANALYSIS; GLOBAL TRANSCRIPTIONAL META ANALYSIS; GROWTH ARREST AND DNA DAMAGE INDUCIBLE 45 GAMMA GENE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; INNATE IMMUNITY; NUCLEOTIDE SEQUENCE; OCT4 GENE; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STABILITY; REPRODUCIBILITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SEQUENCE; RNA TRANSPORT; SECRETED PHOSPHOPROTEIN 1 GENE; SKIN FIBROBLAST; SOLUTE CARRIER FAMILY 16 MEMBER 9 GENE; UPREGULATION; CELL DIFFERENTIATION; CELL LINE; DRUG EFFECTS; GENETICS; META ANALYSIS; METABOLISM; SKIN;

CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; EMBRYONIC STEM CELLS; GENE EXPRESSION; HUMANS; IMMUNITY, INNATE; MONOCARBOXYLIC ACID TRANSPORTERS; NF-KAPPA B; NITRILES; OCTAMER TRANSCRIPTION FACTOR-3; RNA, MESSENGER; SKIN; SULFONES;

EID: 84876129161     PISSN: None     EISSN: 17576512     Source Type: Journal    
DOI: 10.1186/scrt163     Document Type: Article

References (45)

1. The molecular basis of pluripotency in mouse embryonic stem cells. Chambers I, Cloning Stem Cells 2004 6 386 391 10.1089/clo.2004.6.386 15671667 (Pubitemid 40023493)
2. Oct-4 knockdown induces similar patterns of endoderm and trophoblast differentiation markers in human and mouse embryonic stem cells. Hay DC, Sutherland L, Clark J, Burdon T, Stem Cells 2004 22 225 235 10.1634/stemcells. 22-2-225 14990861 (Pubitemid 38282637)
3. Core transcriptional regulatory circuitry in human embryonic stem cells. Boyer LA, Lee TI, Cole MF, Johnstone SE, Levine SS, Zucker JP, Guenther MG, Kumar RM, Murray HL, Jenner RG, Gifford DK, Melton DA, Jaenisch R, Young RA, Cell 2005 122 947 956 10.1016/j.cell.2005.08.020 16153702 (Pubitemid 41345211)
4. Transcriptional activation by oct4 is sufficient for the maintenance and induction of pluripotency. Hammachi F, Morrison GM, Sharov AA, Livigni A, Narayan S, Papapetrou EP, O'Malley J, Kaji K, Ko MS, Ptashne M, Brickman JM, Cell Rep 2012 1 99 109 10.1016/j.celrep.2011.12.002 22832160
5. POU5F1 (OCT3/4) identifies cells with pluripotent potential in human germ cell tumors. Looijenga LH, Stoop H, de Leeuw HP, de Gouveia Brazao CA, Gillis AJ, van Roozendaal KE, van Zoelen EJ, Weber RF, Wolffenbuttel KP, van Dekken H, Honecker F, Bokemeyer C, Perlman EJ, Schneider DT, Kononen J, Sauter G, Oosterhuis JW, Cancer Res 2003 63 2244 2250 12727846 (Pubitemid 36538633)
6. Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4. Nichols J, Zevnik B, Anastassiadis K, Niwa H, Klewe-Nebenius D, Chambers I, Schöler H, Smith A, Cell 1998 95 379 391 10.1016/S0092-8674(00)81769-9 9814708 (Pubitemid 28507326)
7. Beyond homeosis - HOX function in morphogenesis and organogenesis. Hombria JC, Lovegrove B, Differentiation 2003 71 461 476 10.1046/j.1432-0436. 2003.7108004.x 14641327 (Pubitemid 37363662)
8. Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Niwa H, Miyazaki J, Smith AG, Nat Genet 2000 24 372 376 10.1038/74199 10742100 (Pubitemid 30187435)
9. The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells. Loh YH, Wu Q, Chew JL, Vega VB, Zhang W, Chen X, Bourque G, George J, Leong B, Liu J, Wong KY, Sung KW, Lee CW, Zhao XD, Chiu KP, Lipovich L, Kuznetsov VA, Robson P, Stanton LW, Wei CL, Ruan Y, Lim B, Ng HH, Nat Genet 2006 38 431 440 10.1038/ng1760 16518401
10. Identification of Pou5f1, Sox2, and Nanog downstream target genes with statistical confidence by applying a novel algorithm to time course microarray and genome-wide chromatin immunoprecipitation data. Sharov AA, Masui S, Sharova LV, Piao Y, Aiba K, Matoba R, Xin L, Niwa H, Ko MS, BMC Genomics 2008 9 269 10.1186/1471-2164-9-269 18522731 (Pubitemid 351837404)
11. Dissecting Oct3/4-regulated gene networks in embryonic stem cells by expression profiling. Matoba R, Niwa H, Masui S, Ohtsuka S, Carter MG, Sharov AA, Ko MS, PLoS One 2006 1 26 10.1371/journal.pone.0000026 17183653
12. Generation of isogenic pluripotent stem cells. Byrne JA, Hum Mol Genet 2008 17 37 41 10.1093/hmg/ddn053 18632695
13. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Takahashi K, Yamanaka S, Cell 2006 126 663 676 10.1016/j.cell.2006.07.024 16904174 (Pubitemid 44233629)
14. Induced pluripotent stem cell lines derived from human somatic cells. Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S, Nie J, Jonsdottir GA, Ruotti V, Stewart R, Slukvin II, Thomson JA, Science 2007 318 1917 1920 10.1126/science.1151526 18029452
15. Genomic instability and myelodysplasia with monosomy 7 consequent to EVI1 activation after gene therapy for chronic granulomatous disease. Stein S, Ott MG, Schultze-Strasser S, Jauch A, Burwinkel B, Kinner A, Schmidt M, Krämer A, Schwäble J, Glimm H, Koehl U, Preiss C, Ball C, Martin H, Göhring G, Schwarzwaelder K, Hofmann WK, Karakaya K, Tchatchou S, Yang R, Reinecke P, Kühlcke K, Schlegelberger B, Thrasher AJ, Hoelzer D, Seger R, von Kalle C, Grez M, Nat Med 2010 16 198 204 10.1038/nm.2088 20098431
16. Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1. Hacein-Bey-Abina S, Garrigue A, Wang GP, Soulier J, Lim A, Morillon E, Clappier E, Caccavelli L, Delabesse E, Beldjord K, Asnafi V, MacIntyre E, Dal Cortivo L, Radford I, Brousse N, Sigaux F, Moshous D, Hauer J, Borkhardt A, Belohradsky BH, Wintergerst U, Velez MC, Leiva L, Sorensen R, Wulffraat N, Blanche S, Bushman FD, Fischer A, Cavazzana-Calvo M, J Clin Invest 2008 118 3132 3142 10.1172/JCI35700 18688285
17. Transfusion independence and HMGA2 activation after gene therapy of human beta-thalassaemia. Cavazzana-Calvo M, Payen E, Negre O, Wang G, Hehir K, Fusil F, Down J, Denaro M, Brady T, Westerman K, Cavallesco R, Gillet-Legrand B, Caccavelli L, Sgarra R, Maouche-Chrétien L, Bernaudin F, Girot R, Dorazio R, Mulder GJ, Polack A, Bank A, Soulier J, Larghero J, Kabbara N, Dalle B, Gourmel B, Socie G, Chrétien S, Cartier N, Aubourg P, Fischer A, Cornetta K, Galacteros F, Beuzard Y, Gluckman E, Bushman F, Hacein-Bey-Abina S, Leboulch P, Nature 2010 467 318 322 10.1038/nature09328 20844535
18. A more efficient method to generate integration-free human iPS cells. Okita K, Matsumura Y, Sato Y, Okada A, Morizane A, Okamoto S, Hong H, Nakagawa M, Tanabe K, Tezuka K, Shibata T, Kunisada T, Takahashi M, Takahashi J, Saji H, Yamanaka S, Nat Methods 2011 8 409 412 10.1038/nmeth.1591 21460823
19. A nonviral minicircle vector for deriving human iPS cells. Jia F, Wilson KD, Sun N, Gupta DM, Huang M, Li Z, Panetta NJ, Chen ZY, Robbins RC, Kay MA, Longaker MT, Wu JC, Nat Methods 2010 7 197 199 10.1038/nmeth.1426 20139967
20. Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. Kim D, Kim CH, Moon JI, Chung YG, Chang MY, Han BS, Ko S, Yang E, Cha KY, Lanza R, Kim KS, Cell Stem Cell 2009 4 472 476 10.1016/j.stem.2009.05.005 19481515
21. Efficient generation of transgene-free human induced pluripotent stem cells (iPSCs) by temperature-sensitive Sendai virus vectors. Ban H, Nishishita N, Fusaki N, Tabata T, Saeki K, Shikamura M, Takada N, Inoue M, Hasegawa M, Kawamata S, Nishikawa S, Proc Natl Acad Sci USA 2011 108 14234 14239 10.1073/pnas.1103509108 21821793
22. Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome. Fusaki N, Ban H, Nishiyama A, Saeki K, Hasegawa M, Proc Jpn Acad Ser B Phys Biol Sci 2009 85 348 362 10.2183/pjab.85.348 19838014
23. Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Warren L, Manos PD, Ahfeldt T, Loh YH, Li H, Lau F, Ebina W, Mandal PK, Smith ZD, Meissner A, Daley GQ, Brack AS, Collins JJ, Cowan C, Schlaeger TM, Rossi DJ, Cell Stem Cell 2010 7 618 630 10.1016/j.stem.2010.08.012 20888316
24. Highly efficient miRNA-mediated reprogramming of mouse and human somatic cells to pluripotency. Anokye-Danso F, Trivedi CM, Juhr D, Gupta M, Cui Z, Tian Y, Zhang Y, Yang W, Gruber PJ, Epstein JA, Morrisey EE, Cell Stem Cell 2011 8 376 388 10.1016/j.stem.2011.03.001 21474102
25. Single transcription factor reprogramming of hair follicle dermal papilla cells to induced pluripotent stem cells. Tsai SY, Bouwman BA, Ang YS, Kim SJ, Lee DF, Lemischka IR, Rendl M, Stem Cells 2011 29 964 971 10.1002/stem.649 21563278
26. Enhanced generation of induced pluripotent stem cells from a subpopulation of human fibroblasts. Byrne JA, Nguyen HN, Reijo Pera RA, PLoS One 2009 4 7118 10.1371/journal.pone.0007118 19774082
27. Human skin cells that express stage-specific embryonic antigen 3 associate with dermal tissue regeneration. Vega Crespo A, Awe JP, Pera RR, Byrne JA, BioResearch Open Access 2012 1 25 33
28. GeneSifter Microarray Analysis. http://www.geospiza.com
29. Gene Expression Omnibus Genomics Data Repository. http://ncbi.nlm.nih. gov/geo
30. Toll-like receptors. Takeda K, Kaisho T, Akira S, Annu Rev Immunol 2003 21 335 376 10.1146/annurev.immunol.21.120601.141126 12524386 (Pubitemid 37174535)
31. Use of the pharmacological inhibitor BX795 to study the regulation and physiological roles of TBK1 and IkappaB kinase epsilon: a distinct upstream kinase mediates Ser-172 phosphorylation and activation. Clark K, Plater L, Peggie M, Cohen P, J Biol Chem 2009 284 14136 14146 10.1074/jbc.M109.000414 19307177
32. Intracellular toll-like receptors. Blasius AL, Beutler B, Immunity 2010 32 305 315 10.1016/j.immuni.2010.03.012 20346772
33. Innate immune responses in human monocyte-derived dendritic cells are highly dependent on the size and the 5' phosphorylation of RNA molecules. Jiang M, Osterlund P, Sarin LP, Poranen MM, Bamford DH, Guo D, Julkunen I, J Immunol 2011 187 1713 1721 10.4049/jimmunol.1100361 21742966
34. Antiviral signaling through pattern recognition receptors. Kawai T, Akira S, J Biochem 2007 141 137 145 17190786 (Pubitemid 46775751)
35. Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Diebold SS, Kaisho T, Hemmi H, Akira S, Reis e Sousa C, Science 2004 303 1529 1531 10.1126/science.1093616 14976261 (Pubitemid 38314425)
36. Signaling to NF-kappaB by Toll-like receptors. Kawai T, Akira S, Trends Mol Med 2007 13 460 469 10.1016/j.molmed.2007.09.002 18029230 (Pubitemid 350086981)
37. Novel inhibitors of cytokine-induced IkappaBalpha phosphorylation and endothelial cell adhesion molecule expression show anti-inflammatory effects in vivo. Pierce JW, Schoenleber R, Jesmok G, Best J, Moore SA, Collins T, Gerritsen ME, J Biol Chem 1997 272 21096 21103 10.1074/jbc.272.34.21096 9261113 (Pubitemid 27373968)
38. Inhibitor of IkappaB kinase activity, BAY 11-7082, interferes with interferon regulatory factor 7 nuclear translocation and type I interferon production by plasmacytoid dendritic cells. Miyamoto R, Ito T, Nomura S, Amakawa R, Amuro H, Katashiba Y, Ogata M, Murakami N, Shimamoto K, Yamazaki C, Hoshino K, Kaisho T, Fukuhara S, Arthritis Res Ther 2010 12 87 10.1186/ar3014 20470398
39. 5'-Triphosphate RNA is the ligand for RIG-I. Hornung V, Ellegast J, Kim S, Brzózka K, Jung A, Kato H, Poeck H, Akira S, Conzelmann KK, Schlee M, Endres S, Hartmann G, Science 2006 314 994 997 10.1126/science.1132505 17038590 (Pubitemid 44749945)
40. Deletion of the dual specific phosphatase-4 (DUSP-4) gene reveals an essential non-redundant role for MAP kinase phosphatase-2 (MKP-2) in proliferation and cell survival. Lawan A, Al-Harthi S, Cadalbert L, McCluskey AG, Shweash M, Grassia G, Grant A, Boyd M, Currie S, Plevin R, J Biol Chem 2011 286 12933 12943 10.1074/jbc.M110.181370 21317287
41. The low-affinity monocarboxylate transporter MCT4 is adapted to the export of lactate in highly glycolytic cells. Dimmer KS, Friedrich B, Lang F, Deitmer JW, Bröer S, Biochem J 2000 350 219 227 10.1042/0264-6021:3500219 10926847
42. Regulation of monocarboxylate transporter MCT1 expression by p53 mediates inward and outward lactate fluxes in tumors. Boidot R, Végran F, Meulle A, Le Breton A, Dessy C, Sonveaux P, Lizard-Nacol S, Feron O, Cancer Res 2012 72 939 948 10.1158/0008-5472.CAN-11-2474 22184616
43. Sodium butyrate-treated embryonic stem cells yield hepatocyte-like cells expressing a glycolytic phenotype. Sharma NS, Shikhanovich R, Schloss R, Yarmush ML, Biotechnol Bioeng 2006 94 1053 1063 10.1002/bit.20936 16604521 (Pubitemid 44221050)
44. Hyaluronan, CD44, and emmprin regulate lactate efflux and membrane localization of monocarboxylate transporters in human breast carcinoma cells. Slomiany MG, Grass GD, Robertson AD, Yang XY, Maria BL, Beeson C, Toole BP, Cancer Res 2009 69 1293 1301 10.1158/0008-5472.CAN-08-2491 19176383
45. The cytotoxic and immunogenic hurdles associated with non-viral mRNA-mediated reprogramming of human fibroblasts. Drews K, Tavernier G, Demeester J, Lehrach H, De Smedt SC, Rejman J, Adjaye J, Biomaterials 2012 33 4059 4068 10.1016/j.biomaterials.2012.02.025 22381475